Effective March 5, 2018, PathGroup has switched Herpes Simplex Virus 1 and 2 (HSV 1 & 2) detection from a laboratory developed Polymerase Chain Reaction (PCR) methodology to the FDA-approved Aptima HSV 1 & 2 Assay.
For more information, CLICK HERE
News & Events
Effective March 5, 2018, PathGroup has switched Herpes Simplex Virus 1 and 2 (HSV 1 & 2) detection from a laboratory developed Polymerase Chain Reaction (PCR) methodology to the FDA-approved Aptima HSV 1 & 2 Assay.
For more information, CLICK HERE